Please Wait
Applying Filters...
menu
    • menu
    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    Kikkoman Biochemifa Company advances global health and safety through precision-driven innovation in biotech and food testing.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-10-20

    Virtual Booth

    An Enquiry

    Menu

    Tepotinib

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    FDA Approves FoundationOne®Liquid CDx for TEPMETKO® in NSCLC Cancer
    FDA Approves FoundationOne®Liquid CDx for TEPMETKO® in NSCLC Cancer

    18 Nov 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241118083116/en

    BUSINESSWIRE
    18 Nov 2024
    Share Share
    Merck to Highlight Data at ESMO with Potential for Impact on Cancer Patients
    Merck to Highlight Data at ESMO with Potential for Impact on Cancer Patients

    07 Sep 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220907005443/en

    BUSINESSWIRE
    07 Sep 2022
    Share Share
    Merck Europe B.V. Tepmetko(tepotinib) Receives Approval in Europe
    Merck Europe B.V. Tepmetko(tepotinib) Receives Approval in Europe

    05 May 2022

    // EMA

    https://www.ema.europa.eu/en/documents/overview/tepmetko-epar-medicine-overview_en.pdf

    EMA
    05 May 2022
    Share Share
    EC Approves TEPMETKO in Advanced NSCLC with METex14 Skipping Alterations
    EC Approves TEPMETKO in Advanced NSCLC with METex14 Skipping Alterations

    18 Feb 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220217005798/en

    BUSINESSWIRE
    18 Feb 2022
    Share Share
    TEPMETKO Receives Positive CHMP Opinion in Advanced NSCLC
    TEPMETKO Receives Positive CHMP Opinion in Advanced NSCLC

    17 Dec 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20211216005685/en

    BUSINESSWIRE
    17 Dec 2021
    Share Share
    MHRA backs Merck’s MET inhibitor Tepmetko
    MHRA backs Merck’s MET inhibitor Tepmetko

    13 Oct 2021

    // Lucy Parsons PHARMATIMES

    https://www.pharmatimes.com/news/mhra_backs_mercks_met_inhibitor_tepmetko_1380739

    Lucy Parsons PHARMATIMES
    13 Oct 2021
    Share Share